Live Webinar | Legal and Regulatory Compliance
Live Webinar | Health Plan Payment and Reimbursement
Live Webinar | hfma:content/topic/behavioral_ethics
Trend | Clinical Decision Support

The role prescribing guidelines play in patient-monitoring

Trend | Clinical Decision Support

The role prescribing guidelines play in patient-monitoring

According to the Centers for Disease Control and Prevention (CDC), 11.5 million patients are misusing prescription opioids. To prevent and detect opioid misuse, the CDC, Centers for Medicare and Medicaid Services (CMS) and most states have issued prescribing guidelines that include requirements for regularly monitoring the 25 million American patients the CDC reports are prescribed opioid therapy (2018 Annual Surveillance Report of Drug-Related Risks and Outcomes — United States. Surveillance Special Report 2. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Aug. 31, 2018).

While research on the effectiveness of patient monitoring is still in its early stages, an independent health system report presented in April at the Executive War College Conference on Laboratory and Pathology Management showed healthcare providers were able to reduce opioid misuse in their practices by 40% when they followed prescribing guidelines that included regular prescription drug monitoring program (PDMP) checks and toxicology testing. PDMP checks help healthcare providers know which controlled substances a patient received from the pharmacy while toxicology testing serves to verify what the patient is taking.

See related article: Ways to tackle the patient-monitoring process to reduce opioid misuse

Sign up for a free guest account and get access to five free articles every month.


Related Articles | Clinical Decision Support

News | Operations and Other Technology

Policies to prepare for a future pandemic should center on interoperability between hospitals and public health systems, expert says

The need for better interoperability between hospitals and public health entities is a crucial lesson of the COVID-19 pandemic, a public health official testified to a Senate committee.

Blog | Care Management

HHS to provide funding for administration of COVID-19 advanced therapies in vulnerable communities

HHS announced a $150 million investment to make available monoclonal antibody therapeutic treatments for patients in vulnerable communities nationwide.

Trendsetter | Clinical Decision Support

A proactive approach to comprehensive clinical asset management helps healthcare systems maintain financial health

One company discusses its goal to help other health systems in keeping medical equipment throughout its full life expectancy, especially in a time of financial struggle.

News | Leadership Skills Development

Why a crisis makes finance-clinical collaboration more important

Crisis, like the COID-19 pandemic, underscores the need for and benefits from better collaboration between finance and clinical leaders of healthcare organizations.